24 HR Exelon 0.554 MG/HR Transdermal System

RxCUI: 1308571
RxNorm name: 24 HR Exelon 0.554 MG/HR Transdermal System
Display name: 24 HR Exelon 0.554 MG/HR Transdermal System
Full name: 24 HR Exelon 0.554 MG/HR Transdermal System
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Exelon	RIVASTIGMINE	Novartis Pharmaceuticals Corporation	07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0	2024-05-08	Warnings, Adverse reactions	Exact identifier rxcui: 1308571
Exelon	RIVASTIGMINE	Sandoz Inc	b6ed6d15-116d-4596-92ce-3414574d7ba0	2024-05-08	Warnings, Adverse reactions	Exact identifier rxcui: 1308571

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0	EXELON PATCH 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [Exelon] [SBD] · 24 HR Exelon 0.554 MG/HR Transdermal System [SY] · Exelon 13.3 MG per 24HR 1 Day Transdermal Patch [SY] · EXELON PATCH 13.3 MG/Day 24HR Transdermal System [SY]	5	30	These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 2000	20240508
b6ed6d15-116d-4596-92ce-3414574d7ba0	EXELON PATCH 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [Exelon] [SBD] · 24 HR Exelon 0.554 MG/HR Transdermal System [SY] · Exelon 13.3 MG per 24HR 1 Day Transdermal Patch [SY] · EXELON PATCH 13.3 MG/Day 24HR Transdermal System [SY]	5	1	These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 2000	20240508